Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
At close: Aug 20, 2026 · 4:00 PM EDT

Bio-Rad Laboratories (BIO) Sales of Property, Plant and Equipment (2010 - 2026)

Bio-Rad Laboratories (BIO) Sales of Property, Plant and Equipment (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 8.14 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn -100,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -100,000.00
Jun 30, 2026 -100,000.00
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Jun 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Jun 30, 2024 74,000.00
Jun 30, 2024 74,000.00
Mar 31, 2024 26,000.00
Mar 31, 2024 26,000.00
Dec 31, 2023 96,000.00
Dec 31, 2023 96,000.00
Sep 30, 2023 65,000.00
Sep 30, 2023 65,000.00
Jun 30, 2023 39,000.00
Jun 30, 2023 39,000.00
Dec 31, 2022 86,000.00
Dec 31, 2022 86,000.00
Sep 30, 2022 6,000.00
Sep 30, 2022 6,000.00